Dimensional Fund Advisors’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.8M | Sell |
178,152
-329,951
| -65% | -$34.5M | ﹤0.01% | 2006 |
|
|
2026
Q1 | $53.5M | Buy |
508,103
+93,688
| +23% | +$8.3M | 0.01% | 1464 |
|
|
2025
Q4 | $36.2M | Sell |
414,415
-24,100
| -5% | -$1.97M | 0.01% | 1680 |
|
|
2025
Q3 | $29.1M | Buy |
438,515
+258,465
| +144% | +$14.7M | 0.01% | 1812 |
|
|
2025
Q2 | $9.95M | Buy |
180,050
+58,496
| +48% | +$2.81M | ﹤0.01% | 2277 |
|
|
2025
Q1 | $5.88M | Sell |
121,554
-104,046
| -46% | -$4.36M | ﹤0.01% | 2453 |
|
|
2024
Q4 | $8.71M | Buy |
225,600
+11
| +0% | +$480 | ﹤0.01% | 2360 |
|
|
2024
Q3 | $10.2M | Sell |
225,589
-390,583
| -63% | -$15.8M | ﹤0.01% | 2303 |
|
|
2024
Q2 | $21.3M | Sell |
616,172
-175,172
| -22% | -$5.13M | 0.01% | 1929 |
|
|
2024
Q1 | $22.9M | Sell |
791,344
-25,193
| -3% | -$685K | 0.01% | 1914 |
|
|
2023
Q4 | $18.7M | Sell |
816,537
-124,737
| -13% | -$2.18M | 0.01% | 2019 |
|
|
2023
Q3 | $15.7M | Sell |
941,274
-97,831
| -9% | -$1.9M | 0.01% | 2052 |
|
|
2023
Q2 | $28.7M | Sell |
1,039,105
-223,154
| -18% | -$5.58M | 0.01% | 1728 |
|
|
2023
Q1 | $29M | Buy |
+1,262,259
| New | +$21.2M | 0.01% | 1706 |
|
|
2022
Q3 | $6.92M | Sell |
820,438
-32,337
| -4% | -$306K | ﹤0.01% | 2308 |
|
|
2022
Q2 | $6.75M | Sell |
852,775
-10,117
| -1% | -$122K | ﹤0.01% | 2352 |
|
|
2022
Q1 | $20.4M | Sell |
862,892
-11,759
| -1% | -$331K | 0.01% | 1953 |
|
|
2021
Q4 | $29.9M | Sell |
874,651
-1,081
| -0.1% | -$34.2K | 0.01% | 1765 |
|
|
2021
Q3 | $15.5M | Buy |
875,732
+84,716
| +11% | +$3.61M | 0.01% | 2121 |
|
|
2021
Q2 | $35.5M | Buy |
791,016
+134,915
| +21% | +$4.45M | 0.01% | 1710 |
|
|
2021
Q1 | $17M | Buy |
656,101
+6,561
| +1% | +$166K | 0.01% | 2089 |
|
|
2020
Q4 | $13.1M | Sell |
649,540
-35,716
| -5% | -$769K | ﹤0.01% | 2174 |
|
|
2020
Q3 | $13.4M | Sell |
685,256
-1,641
| -0.2% | -$30.8K | 0.01% | 2057 |
|
|
2020
Q2 | $12.1M | Buy |
686,897
+13,249
| +2% | +$166K | 0.01% | 2130 |
|
|
2020
Q1 | $4.76M | Buy |
673,648
+2,897
| +0.4% | +$21.7K | ﹤0.01% | 2427 |
|
|
2019
Q4 | $4.73M | Sell |
670,751
-60,554
| -8% | -$601K | ﹤0.01% | 2629 |
|
|
2019
Q3 | $8.78M | Sell |
731,305
-12,753
| -2% | -$161K | ﹤0.01% | 2396 |
|
|
2019
Q2 | $9.01M | Buy |
744,058
+80,281
| +12% | +$888K | ﹤0.01% | 2429 |
|
|
2019
Q1 | $8.34M | Buy |
663,777
+173,510
| +35% | +$1.53M | ﹤0.01% | 2471 |
|
|
2018
Q4 | $3.3M | Buy |
490,267
+122,250
| +33% | +$970K | ﹤0.01% | 2720 |
|
|
2018
Q3 | $3.79M | Buy |
368,017
+140,200
| +62% | +$1.21M | ﹤0.01% | 2766 |
|
|
2018
Q2 | $1.53M | Buy |
+227,817
| New | +$1.75M | ﹤0.01% | 2942 |
|
Other funds holding PTGX
FCM
RI
JJ
Dimensional Fund Advisors's PTGX Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its Protagonist Therapeutics (PTGX) stake by 65% in Q2 2026, selling an estimated $34.5M and leaving 178,152 shares worth $21.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2006.
Dimensional Fund Advisors first reported a position in PTGX in Q2 2018 and has held it in 32 quarters since. The position peaked at $53.5M in Q1 2026. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.
- Dimensional Fund Advisors held 178,152 shares of Protagonist Therapeutics worth $21.8M as of Q2 2026.
- Dimensional Fund Advisors sold 329,951 Protagonist Therapeutics shares in Q2 2026, an estimated $34.5M.
- Protagonist Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2006 holding.
- Dimensional Fund Advisors first reported a position in Protagonist Therapeutics in Q2 2018 and has held it in 32 quarters since.
- Dimensional Fund Advisors's Protagonist Therapeutics position peaked at $53.5M in Q1 2026.
- 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.